Continuous Glucose Monitoring Device Market Growth & Trends
The global continuous glucose monitoring device market size is expected to reach USD 10.36 billion by 2028, according to a new study by Grand View Research, Inc. It is expected to expand at a CAGR of 10.1% from 2021 to 2028. Growing cases of diabetes and introduction of novel and advanced diabetes care devices are the major factors driving the market growth. Continuous glucose monitoring (CGM) devices provide an efficient method to measure body glucose levels in real time. Data recorded by these devices is transmitted through a wireless network to receivers; this helps keep a track of glucose levels over a designated period.
These devices also help manage diabetes while reducing individual insulin dosages. Integrated software within these devices provides users with insights about food consumption, medication, physical activity, and illnesses. Thus, an increasing number of diabetic patients are using these devices to manage and treat diabetes, which, in turn, is accelerating market growth. With the advent of digital therapeutics, a rising number of continuous glucose monitoring devices are being incorporated with apps and software to help patients with diabetes mellitus. Rise in the number of diabetes mellitus has been contributing toward continuous glucose monitoring (CGM) systems market growth.
Request a free sample copy or view report summary: Continuous Glucose Monitoring Device Market Report
Continuous Glucose Monitoring Device Market Report Highlights
- Growing cases of diabetes is anticipated to propel market growth, with increasing number of patients opting for simplified CGM devices
- CGM devices provide analysis of blood glucose levels from the tissue fluid at regular intervals of time, which is also driving their demand
- Sensors was the largest component type segment and is anticipated to maintain its dominance owing to their integral nature in these devices
- Asia Pacific is the leading regional continuous glucose monitoring device market, with Japan, China, and India on the forefront
- North America led the global market in the past owing to wide usage of CGM devices as a result of higher number of target patients in the region
- The European region followed the North American closely in terms of market revenue due to rise in the adoption of these devices in key countries such as U.K., Germany, France, Italy, and Spain
- Some of the key companies present in the market are Pfizer Inc.; Baxter International, Inc.; Abbott Laboratories; Medtronic PLC; Animas Corporation; and Novo Nordisk A/S.
Access Press Release@ https://www.grandviewresearch.com/press-release/global-continuous-glucose-monitoring-cgm-devices-market
Continuous Glucose Monitoring Device Market Segmentation
Grand View Research has segmented the global continuous glucose monitoring device market on the basis of component, end use, and region:
CGM Devices Component Outlook (Revenue, USD Million, 2016 - 2028)
- Transmitters
- Sensors
- Receivers
CGM Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)
- Hospitals
- Home Care
- Others
CGM Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)
- North America
- US.
- Canada
- Europe
- Germany
- UK.
- Asia Pacific
- China
- India
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
- Saudi Arabia
List of Key Players of Continuous Glucose Monitoring Device Market
- Medtronic
- Dexcom, Inc.
- Hoffmann-La Roche Ltd.
- Abbott
- Novo Nordisk A/S
- Ypsomed
- GlySens, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment